Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04908605Phase 4Completed
Phase 4, randomised, double-blind trial in Emergence agitation (EA) comparing Mirtazapine group, Melatonin group and Placebo group (3 arms). Primary endpoint: Total number of patients with the Riker sedation-agitation score ≥5. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04908605.